A Memorial Sloan Kettering Cancer Center study reveals new details about how pancreatic cells carrying oncogenic mutations transition from benign to malignant — shining new light on the ecosystem that ...

An engineered enzyme is at the center of a new method to visualize molecular details in human cells, and how these molecules change in cancerous versus benign cells, report Boston College researchers ...

An engineered enzyme is at the center of a new method to visualize molecular details in human cells, and how these molecules change in cancerous versus benign cells, Boston College researchers have ...

Peter Westcott (left) runs an independent research group at Cold Spring Harbor Laboratory (NY, USA), which is interested in how cancer interacts with the immune system and other normal cells in the ...

Improved detection of circulating tumor DNA in patients with leiomyosarcoma with fragment size restriction. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...